Alkermes (ALKS) Change in Inventory (2016 - 2026)
Alkermes' (ALKS) quarterly Change in Inventory came in at $6.4 million in Q1 2026, up 267.05% year-on-year from $1.8 million in Q1 2025, and up 32.16% on a QoQ basis from $4.9 million in Q4 2025.
Alkermes (ALKS) Change in Inventory (2016 - 2026) Analysis & Trends
Alkermes (ALKS) has 11 years of Change in Inventory data on file, last reported at $6.4 million in Q1 2026.
- On a quarterly basis, Change in Inventory rose 267.05% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $18.7 million, a 234.02% increase from a year earlier, with the FY2025 full-year figure at $14.1 million, up 554.9% from the prior year.
- Change in Inventory for Q1 2026 stood at $6.4 million, up from $4.9 million in the prior quarter.
- Over the last five years, Change in Inventory for ALKS reached as high as $15.4 million in Q4 2022 and fell as low as -$9.1 million in Q4 2024.
- Historically, Change in Inventory has averaged $3.0 million across 5 years, with a median of $3.0 million in 2023.
- Across the five-year window, Change in Inventory surged 1607.75% in 2023 and tumbled 216.74% in 2024, its largest moves.
- Year by year, Change in Inventory stood at $15.4 million in 2022, then slumped by 146.53% to -$7.2 million in 2023, then fell by 27.79% to -$9.1 million in 2024, then surged by 153.19% to $4.9 million in 2025, then soared by 32.16% to $6.4 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $6.4 million in Q1 2026, $4.9 million in Q4 2025, and -$845000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn | 6.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.43 Mn |
| Mar 31, 2026 | 6.43 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Dec 31, 2025 | 4.86 Mn |
| Sep 30, 2025 | -845,000.00 |
| Sep 30, 2025 | -845,000.00 |
| Jun 30, 2025 | 8.29 Mn |
| Jun 30, 2025 | 8.29 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | -9.14 Mn |
| Dec 31, 2024 | -9.14 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Sep 30, 2024 | -3.49 Mn |
| Jun 30, 2024 | -3.10 Mn |
| Jun 30, 2024 | -3.10 Mn |
| Mar 31, 2024 | 12.64 Mn |
| Mar 31, 2024 | 12.64 Mn |
| Dec 31, 2023 | -7.15 Mn |
| Dec 31, 2023 | -7.15 Mn |